Skip to main content
. 2023 Jun 1;43(3):203–211. doi: 10.14639/0392-100X-N1902

Table III.

Predictive factors for long-term complications

All patients (N = 77) No complications (N = 41) Complications (N = 36) Univariate Multivariate
P OR (95% CI) P OR (95% CI)
Gender, no. (%)
    Female 33(43) 16(44) 17(42)
    Male 44(57) 20(56) 24(59) 0.792 0.89 (0.36-2.19)
Median age, years (range) 65 (22-96) 67 (22-93) 65 (26-96) 0.573 0.99 (0.96-1.02)
Smoker, no. (%)
    No 49(64) 26(72) 23(56)
    Yes 28(36) 10(28) 18(44) 0.145 2.04 (0.78-5.29) 0.128 2.71 (0.75-9.83)
CCI, no. (%)
    ≤ 2 32(42) 13(36) 19(46)
    > 2 45(58) 23(64) 22(54) 0.364 0.65 (0.26-1.64)
Stage, no. (%)
    1-2 29(38) 18(50) 11(27)
    3-4 48(62) 18(50) 30(73) 0.039* 2.73 (1.05-7.06) 0.661 1.31 (0.39-4.34)
Management, no. (%)
    Surgery alone 17(22) 15(42) 2(5)
    Adjuvant or definitive RT/CRT 60(78) 21(58) 39(95) 0.001* 13.93 (2.90-66.81) 0.001* 18.86 (3.31-107.6)
Surgery type, no. (%)
    Open 32(50) 14(47) 18(53)
    Endoscopic 27(42) 13(43) 14(41) 0.736 0.84 (0.30-2.34)
    Combined 5(8) 3(10) 2(6) 0.503 0.52 (0.76-3.54)
RT/CRT, no. (%)
    RT 40(67) 15(71) 25(64)
    CRT 20(33) 6(29) 14(36) 0.567 1.40 (0.44-4.43)
Radiation modality, no. (%)
    External beam radiation 23(38) 11(52) 12(31)
    IMRT 37(62) 10(48) 27(69) 0.104 2.48 (0.83-7.38) 0.135 2.36 (0.77-7.29)
Radiation dose, no. (%)
    < 60 Gy 12(25) 5(33) 7(21)
    ≥ 60 Gy 36(75) 10(67) 26(79) 0.372 1.86 (0.48-7.23)
CCI: Charlson comorbidity index; RT: radiotherapy; CRT: chemoradiotherapy; IMRT: intensity-modulated radiation therapy; Gy: Gray; OR: odds ratio; CI: confidence interval; * Statistically significant. Variables with a two-sided p-value < 0.2 from univariate analysis were included in a multivariate analysis.